CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) saw a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 12,700 shares, a growth of 12,600.0% from the November 30th total of 100 shares. Based on an average trading volume of 90,800 shares, the short-interest ratio is presently 0.1 days.
CSPC Pharmaceutical Group Trading Up -0.2 %
CSPCY stock traded up C$0.02 during midday trading on Thursday, reaching C$2.44. 3,787 shares of the company’s stock traded hands, compared to its average volume of 40,227. The company has a 50-day simple moving average of C$2.69 and a two-hundred day simple moving average of C$2.84. CSPC Pharmaceutical Group has a 1-year low of C$2.25 and a 1-year high of C$3.82.
CSPC Pharmaceutical Group Increases Dividend
The business also recently announced a dividend, which was paid on Thursday, December 5th. Shareholders of record on Friday, November 1st were paid a $0.0575 dividend. The ex-dividend date of this dividend was Friday, November 1st. This is an increase from CSPC Pharmaceutical Group’s previous dividend of $0.06.
CSPC Pharmaceutical Group Company Profile
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.
Featured Stories
- Five stocks we like better than CSPC Pharmaceutical Group
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Top 3 Investment Themes to Watch for in 2025
- What Are the FAANG Stocks and Are They Good Investments?
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- Stock Sentiment Analysis: How it Works
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.